PP_1170x120_10-25-21

The National Pharmaceutical Council (NPC)

NPC appoints Sharon Phares chief scientific officer

NPC appoints Sharon Phares chief scientific officer

WASHINGTON – The National Pharmaceutical Council (NPC) announced on Tuesday the appointment of Sharon Phares as chief scientific officer. Dr. Phares will replace Dr. Robert Dubois, who is retiring from NPC at the end of February 2022. Dr. Phares, who assumes the role today, will direct NPC’s research strategy and oversee the organization’s research on

New study shows patient input in drug coverage policy is missing

New study shows patient input in drug coverage policy is missing

WASHINGTON — Patients are being asked to shoulder more and more of the costs for their health care, yet health insurance plans aren’t asking patients for input when developing specialty drug coverage policies, according to a study published this week in the Journal of Managed Care & Specialty Pharmacy. The study, written by researchers from

NPC names Dr. Robert Dubois as interim president and CEO

NPC names Dr. Robert Dubois as interim president and CEO

WASHINGTON — The National Pharmaceutical Council (NPC) announced on Tuesday the appointment of Dr. Robert Dubois, as its interim president and CEO. The NPC board of directors will conduct a national search for a permanent replacement for Dan Leonard, who stepped down as NPC’s president and CEO after more than 12 years of service. “Dr.

NPC announces departure of president and CEO Dan Leonard

NPC announces departure of president and CEO Dan Leonard

WASHINGTON — The National Pharmaceutical Council (NPC) announced Tuesday that Dan Leonard will be stepping down as president and chief executive officer, effective September 4. “Under his leadership, NPC became a leading voice explaining how medicines bring value to our health system and society. Dan increased its membership, expanded its staff, and strengthened its reputation

Johnson & Johnson’s Penkowski elected NPC board chair

Johnson & Johnson’s Penkowski elected NPC board chair

WASHINGTON — The National Pharmaceutical Council (NPC)  announced that Blasine Penkowski, chief strategic customer officer of Johnson & Johnson Health Care Systems Inc., has been elected chair of NPC’s board of directors for 2019-2020. Penkowski has served in other NPC board positions, most recently as vice chair. “Companies driving biopharmaceutical innovation face diverse challenges in

Celgene’s Richard Bagger elected NPC board chair

Celgene’s Richard Bagger elected NPC board chair

WASHINGTON — The National Pharmaceutical Council (NPC) today announced that Richard Bagger, executive vice president, corporate affairs and market access, Celgene Corp., has been elected chair of NPC’s board of directors for 2018-2019. Bagger has previously served in several leadership roles at NPC, including as vice chair and treasurer. “Rich’s deep experience in health care, particularly